• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Calming and Sleeping in the United Arab Emirates

  • ID: 2477276
  • June 2015
  • Region: United Arab Emirates
  • 24 pages
  • Euromonitor International

Health experts have claimed that Dubai’s citizens suffer from high levels of stress, with symptoms of this including musculoskeletal disorders, insomnia, ulcers, and in some cases, panic attacks. In addition, according to one recent survey which became public in 2013, some 50% of the population of the United Arab Emirates suffers from poor sleep on a regular basis.

The Calming and Sleeping in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the Calming and Sleeping market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

CALMING AND SLEEPING IN THE UNITED ARAB EMIRATES

June 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2009-2014
Table 2 Sales of Calming and Sleeping: % Value Growth 2009-2014
Table 3 NBO Company Shares of Calming and Sleeping: % Value 2010-2014
Table 4 LBN Brand Shares of Calming and Sleeping: % Value 2011-2014
Table 5 Forecast Sales of Calming and Sleeping: Value 2014-2019
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2014-2019
Julphar Gulf Pharmaceuticals in Consumer Health (united Arab Emirates)
Strategic Direction
Key Facts
Summary 1 Julphar Gulf Pharmaceutical: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 2 Julphar Gulf Pharmaceutical: Competitive Position 2014
Executive Summary
Healthy Growth Continues in Consumer Health in the United Arab Emirates in 2014
Forecast Value Growth Is Threatened by GCC Price Harmonisation Initiative
the Strong Consumer Preference for Branded Products Is Difficult To Change
Chemists/pharmacies Continues To Lose Share
Strong Demand for Rx Products Poses A Threat To Demand for OTC Medicines
Key Trends and Developments
OTC Products Sees Healthy Growth in 2014, Driven by Growing Awareness of and Interest in Consumer Health
Raising Awareness of the Country's Rising Obesity Problem Is One of the Key Aims of the Government
GCC Price Harmonisation Impacts Development
Doctors Are Frequently Bypassed, As Patients Seek Advice From Pharmacists Or "dr Google"
50+ Age Group Becomes the Major Target of Marketing Campaigns for Vitamins and Dietary Supplements
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 8 Life Expectancy at Birth 2009-2014
Market Data
Table 9 Sales of Consumer Health by Category: Value 2009-2014
Table 10 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 11 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 12 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 13 Distribution of Consumer Health by Format: % Value 2009-2014
Table 14 Distribution of Consumer Health by Format and Category: % Value 2014
Table 15 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Sources
Summary 3 Research Sources

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S